Navigation Links
Nyenrode Honorary Doctorate for Professor Michael E. Porter
Date:2/20/2009

BREUKELEN, The Netherlands, February 20 /PRNewswire/ -- Nyenrode Business Universiteit has awarded a Honorary Doctoral degree to Professor Michael Porter, icon in the field of microeconomics, competitive strategy and cluster theory. Professor Porter is generally considered as the father of the modern field of strategy and the world's most influential thought leader in the field of management and competitive strategy. Professor Porter will receive the Honorary Doctorate on Wednesday May 13, in Breukelen. Earlier that day he will take part in the official opening of the Nyenrode Institute of Life Sciences and Healthcare and will give a short lecture on the Dutch Biotech Cluster. Professor Porter's promotor is Professor Dr. Fred van Eenennaam, Director of the Nyenrode Strategy Center and chairman of the Nyenrode Institute of Life Sciences and Healthcare. Professor Porter has a longstanding relationship with Nyenrode and the Nyenrode Strategy Center led by prof. dr. Fred van Eenennaam.

Prof. dr. Bert de Groot, Dean en Rector Magnificus: "Professor Porter has great influence on the field of business administration. Nyenrode admires his contributions to science, economy and society and we feel very honored that he has accepted our Honorary Doctorate. Porter's leadership and devoted efforts to society inspire scholars and students worldwide."

Professor Porter, professor at the Harvard Business School, has done groundbreaking work in the field of competitive strategy. His The Competitive Advantage of Nations, presents a theory of how nations and regions compete and their sources of economic prosperity.

The ideas of professor Porter form the basis for courses on strategy and competitiveness, and are being taught to students of economics and business administration worldwide. His more recent work focuses on the application of competitive strategy to social issues, the healthcare system, corporate social responsibility, philanthropy and leadership.

Next to his academic career, professor Porter has held several positions as strategy advisor to the top management of many leading U.S. and international companies.

Professor Porter plays an active role in advising U.S. and foreign governments. He is actively involved in U.S. economic policy making with the Executive Branch, Congress, and international organizations.

On May 13 professor Porter will also be a key note speaker at the opening seminar of the Nyenrode Institute of Life Sciences and Healthcare.


'/>"/>
SOURCE Nyenrode Business Universiteit
Copyright©2009 PR Newswire.
All rights reserved

Related biology technology :

1. Physics professor lauded for NSF efforts with prestigious award
2. Physics professor lauded for NSF efforts with prestigious award
3. Japanese Cancer Association and Debiopharm Honour Professors Minoru Toyota and Keiichi Nakayama With the 2007 JCA-Mauvernay Award
4. Dr. Thomas Van Dyke Renowned Boston University Professor Joins Imagenetixs Medical Advisory Board
5. Helix Biopharma announces addition of University of Arizona professor Kenneth Hatch as new medical advisor
6. Cambridge Major Appoints Professor John Hartwig as Scientific Advisor
7. Professor Straufs research is Nature Photonics’ cover article
8. Professor Toh-Ming Lu named fellow of the Materials Research Society
9. Professors Marc Feldmann and Sir Ravinder Maini Named Winners of the 2008 Dr. Paul Janssen Award for Biomedical Research
10. Professor-turned-producer learns the movie biz
11. UCF professor develops vaccine to protect against black plague bioterror attack
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/27/2016)... PHILADELPHIA , June 27, 2016  Liquid ... today announced the funding of a Sponsored Research ... study circulating tumor cells (CTCs) from cancer patients.  ... changes in CTC levels correlate with clinical outcomes ... therapies. These data will then be employed to ...
(Date:6/24/2016)... 24, 2016 Epic Sciences unveiled a ... susceptible to PARP inhibitors by targeting homologous recombination ... The new test has already been incorporated into ... cancer types. Over 230 clinical trials ... pathways, including PARP, ATM, ATR, DNA-PK and WEE-1. ...
(Date:6/23/2016)... ... 23, 2016 , ... Mosio, a leader in clinical research ... Recruitment and Retention Tips.” Partnering with experienced clinical research professionals, Mosio revisits the ... tools, and strategies for clinical researchers. , “The landscape of how patients receive ...
(Date:6/23/2016)... 2016 /PRNewswire/ - FACIT has announced the creation ... biotechnology company, Propellon Therapeutics Inc. ("Propellon" or "the ... a portfolio of first-in-class WDR5 inhibitors for the ... WDR5 represent an exciting class of therapies, possessing ... for cancer patients. Substantial advances have been achieved ...
Breaking Biology Technology:
(Date:5/9/2016)... May 9, 2016 Elevay is ... to expanding freedom for high net worth professionals seeking ... today,s globally connected world, there is still no substitute ... ever duplicate sealing your deal with a firm handshake. ... by taking advantage of citizenship via investment programs like ...
(Date:4/26/2016)... -- Research and Markets has announced the ...  report to their offering.  , ,     (Logo: ... forecast the global multimodal biometrics market to grow ... 2016-2020.  Multimodal biometrics is being implemented ... healthcare, BFSI, transportation, automotive, and government for controlling ...
(Date:4/13/2016)... physicians supporting Medicaid patients in Central Florida ... telehealth thanks to a new partnership with higi.   ... can routinely track key health measurements, such as blood ... they opt in, share them with IMPOWER clinicians through ... location at no cost. By leveraging this data, IMPOWER ...
Breaking Biology News(10 mins):